The next head of the U.S. Food and Drug Administration will find a plate full of important legal and regulatory issues, and not just for lawyers engaged in basic food, drug and health law.
Also on the front burner for the successor to FDA Commissioner Margaret Hamburg, who announced Feb. 5 that she would step down next month, will be patent, intellectual property and information-technology matters. Such is the reach of an agency considered the broadest and most powerful regulatory body in the world.
